Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SYMBYX Biome is an Australian medical technology company developing and commercializing at-home photobiomodulation and low-level laser therapy devices for chronic neurological and pain-related conditions. The company is best known for its Parkinson's-focused products, including handheld laser devices and a transcranial light therapy helmet, and positions its offerings as research-backed, non-invasive adjunctive therapies. SYMBYX emphasizes clinical evidence, remote/home use, and clinician-supported deployment of its devices. Its portfolio spans wellness and medical-grade laser products aimed at symptom management rather than traditional drug development. The company appears to operate primarily as a private commercial-stage medtech business rather than a biotech therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SYMBYX Biome.